分子诊断的全球市场，预测到 2029 年

分子诊断激发成长机会并推动创新的个人化医疗

由于多种因素，包括 COVID-19 大流行导致的需求增加、癌症病例数量增加以及技术力的快速发展，全球分子诊断市场预计将显着增长。

聚合酵素链锁反应(PCR)、数位 PCR 和次世代定序(NGS) 等技术的进步提高了分子检测的准确性和生产力，并实现了个人化治疗。

预测分析按区域和应用程式进行细分。后者包括传染病检查、肿瘤学检测、基因检测和其他分子诊断。由于方法上的限制，Frost & Sullivan对该行业的预测采用定性方法进行成长机会分析。

癌症发生率的增加加速了对先进分子诊断工具的需求，而慢性病的增加、政府医疗保健的现代化以及对个人化医疗的需求不断增加将推动分子诊断行业的显着增长。集中的医疗监管和强大的研发投资将促进这一扩张。

目录

成长环境

• 成长环境

策略要务

• 为什么成长如此困难？
• The Strategic Imperative 8（TM）
• 关键策略要务对全球分子诊断产业的影响
• 全球分子诊断公司的策略要务
• 成长机会推动Growth Pipeline Engine（TM）

成长机会分析

• 分析范围
• 全球分子诊断的应用细分

概述

• 成长指标
• 生长促进因子
• 成长抑制因素
• 预测假设

收益预测

• 收益预测
• 全球分子诊断收益预测分析
• 按地区分類的收益预测
• 全球分子诊断收益预测分析（按地区）
• 全球分子诊断市场分析（按技术）
• 收益预测（按使用情况）
• 按应用分類的全球分子诊断收益预测

竞争格局

• 竞争环境
• 全球分子诊断公司收益占有率
• 全球分子诊断收益占有率分析
• 主要竞争对手
• 透过分子诊断产品进行竞争性绘图

併购

• 全球分子诊断市场：值得关注的併购

特色企业

• 分子诊断领域的知名公司

成长机会宇宙

• 成长机会概览
• 成长机会1：POC测试的进步
• 成长机会2：发现遗传标记和疗法的个人化癌症治疗
• 成长机会3：利用下一代分子诊断技术整合生物标记开发与伴同性诊断
• 成长机会4：加强居家健康监测

下一步

Molecular Diagnostics Unleash Growth Opportunities, Steering Innovation Personalized Medicine

The global molecular diagnostic market will experience significant growth due to a broad range of factors, such as increased demand from the COVID-19 pandemic, an increasing number of cancer cases, and the swift evolution of technological capabilities.

Technological advancements, such as polymerase chain reaction (PCR), digital PCR, and next-generation sequencing (NGS), have improved molecular testing accuracy and productivity, enabling personalized treatment.

The forecast analysis is segmented by region and by application. The latter includes infectious disease testing, oncology testing, genetic testing, and other molecular diagnostics. Frost & Sullivan's forecasts for this industry use a qualitative approach for the growth opportunity analyses due to methodological constraints.

The growing prevalence of cancer has accelerated the need for advanced molecular diagnostic tools, while the rise in chronic diseases, the modernization of government healthcare, and the growing demand for personalized medicine will contribute to the significant growth anticipated in the molecular diagnostics industry. Focused healthcare regulations and substantial R&D investments facilitate this expansion.

Table of Contents

Growth Environment

• Growth Environment

Strategic Imperatives

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Global Molecular Diagnostics Industry
• Strategic Imperatives for Global Molecular Diagnostics Companies
• Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

• Scope of Analysis
• Global Molecular Diagnostics Application Segmentation

Overview

• Growth Metrics
• Growth Drivers
• Growth Restraints
• Forecast Assumptions

Revenue Forecast

• Revenue Forecast
• Global Molecular Diagnostics Revenue Forecast Analysis
• Revenue Forecast by Region
• Global Molecular Diagnostics Revenue Forecast Analysis by Region
• Global Molecular Diagnostics Market Analysis by Technology
• Revenue Forecast by Application
• Global Molecular Diagnostics Revenue Forecast by Application

Competitive Landscape

• Competitive Environment
• Global Molecular Diagnostics Revenue Share by Player
• Global Molecular Diagnostics Revenue Share Analysis
• Key Competitors
• Competitive Mapping by Molecular Diagnostics Offering

Mergers and Acquisitions

• Global Molecular Diagnostics Market: Notable M&A

Companies to Watch

• Molecular Diagnostics Companies to Watch

Growth Opportunity Universe

• Growth Opportunity Summary
• Growth Opportunity 1: Advancements in Point-of-care Testing
• Growth Opportunity 2: Personalized Cancer Treatment Unveiling Genetic Markers and Therapies
• Growth Opportunity 3: Leveraging Next-gen Molecular Diagnostics Technologies for Biomarker Development and Companion Diagnostics Integration
• Growth Opportunity 4: Enhancing Home Health Monitoring

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• List of Exhibits
• Legal Disclaimer